NCT03542656View on ClinicalTrials.gov

Application of Amyloid PET in Cerebral Amyloid Angiopathy

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 11, 2014

Primary Completion Date

February 17, 2016

Study Completion Date

March 22, 2018

Conditions
Cerebral Amyloid AngiopathyIntracranial HemorrhagesAlzheimer Disease
Interventions
DRUG

amyloid PET

Dynamic PET acquisition for 60 minutes will be acquired after injection of 10 mCi 11C-PiB (39 frames: 8 x 15 seconds, 4 x 60 seconds, 27 x120 seconds).

Trial Locations (1)

100

National Taiwan Univeristy Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03542656 - Application of Amyloid PET in Cerebral Amyloid Angiopathy | Biotech Hunter | Biotech Hunter